Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors
- 1 February 2009
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 202 (2), 455-460
- https://doi.org/10.1016/j.atherosclerosis.2008.05.015
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistancePhysiology & Behavior, 2007
- Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies: The Fibrinogen Studies CollaborationAmerican Journal of Epidemiology, 2007
- Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular diseaseCurrent Opinion in Lipidology, 2007
- Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66(ShcA) in pacemaker-implanted patientsClinical and Experimental Medicine, 2007
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cellsAtherosclerosis, 2004
- Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesisBlood, 2004
- The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activationJournal of Leukocyte Biology, 2004
- Characterization of the long pentraxin PTX3 as a TNFα-induced secreted protein of adipose cellsJournal of Lipid Research, 2003
- Characterization of high density lipoprotein binding to human adipocyte plasma membranes.JCI Insight, 1985